Canaccord Genuity lifts Twist Bioscience target to $205 per share
Canaccord Genuity raised its price target for Twist Bioscience from $120 to $205 per share, according to an analyst-rating update cited by Newsmetry API.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
Newsmetry API reported that Canaccord Genuity increased its price target for Twist Bioscience shares to $205.00 from $120.00 per share.
The update is part of the analyst ratings information published by Benzinga.
why it matters
A revised price target signals a change in the analyst’s assessment of the company and may be considered by investors evaluating TWST shares.
instruments
sources
- Twist Bioscience Price Target Raised to $205.00/Share From $120.00 by Canaccord Genuity — Newsmetry API, 12 October 2026 at 17:15 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗